Science

Feb 13, 2025, 17:00

Myeloma Paper of the Day, February 12th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CAR+ T-cell lymphoma after cilta-cel therapy for relapsed or refractory myeloma that developed in two patients treated on the phase 3 CARTITUDE-4 trial who had evidence of detectable CAR transgene expression and integration.”

“CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma”

Authors: Simon Harrison, Cyrille Touzeau, Nicolas Kint, Benoit Tessoulin, Piers Blombery et al.

More posts featuring Robert Orlowski.

Benoit Tessoulin cancer CAR+ T-cell lymphoma CARTITUDE-4 Cilta-cel Therapy Cyrille Touzeau Myeloma Paper of the Day Nicolas Kint OncoDaily Oncology Piers Blombery refractory myeloma relapsed myeloma Robert Orlowski Simon Harrison

New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer

Kimryn Rathmell was Awarded 2025 ACS Medal of Honor

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!